259 related articles for article (PubMed ID: 12057102)
1. Malignant peritoneal mesothelioma.
Loggie BW
Curr Treat Options Oncol; 2001 Oct; 2(5):395-9. PubMed ID: 12057102
[TBL] [Abstract][Full Text] [Related]
2. Diffuse malignant peritoneal mesothelioma--an update on treatment.
Mirarabshahii P; Pillai K; Chua TC; Pourgholami MH; Morris DL
Cancer Treat Rev; 2012 Oct; 38(6):605-12. PubMed ID: 22104079
[TBL] [Abstract][Full Text] [Related]
3. Cytoreductive surgery with intraperitoneal hyperthermic chemotherapy for malignant peritoneal mesothelioma: mitomycin versus cisplatin.
Blackham AU; Shen P; Stewart JH; Russell GB; Levine EA
Ann Surg Oncol; 2010 Oct; 17(10):2720-7. PubMed ID: 20422458
[TBL] [Abstract][Full Text] [Related]
4. Peritoneal mesothelioma: the site of origin matters.
Kindler HL
Am Soc Clin Oncol Educ Book; 2013; ():182-8. PubMed ID: 23714495
[TBL] [Abstract][Full Text] [Related]
5. Peritoneal mesothelioma treated by induction chemotherapy, cytoreductive surgery, and intraperitoneal hyperthermic perfusion.
Deraco M; Casali P; Inglese MG; Baratti D; Pennacchioli E; Bertulli R; Kusamura S
J Surg Oncol; 2003 Jul; 83(3):147-53. PubMed ID: 12827682
[TBL] [Abstract][Full Text] [Related]
6. [Treatment of peritoneal mesothelioma using cytoreduction and intraperitoneal hyperthermic chemotherapy].
Costamagna D; Scuderi S; Vaira M; Barone R; De Simone M
Tumori; 2003; 89(4 Suppl):40-2. PubMed ID: 12903541
[TBL] [Abstract][Full Text] [Related]
7. Treatment of Malignant Peritoneal Mesothelioma.
Levý M; Boublíková L; Büchler T; Šimša J
Klin Onkol; 2019; 32(5):333-337. PubMed ID: 31610664
[TBL] [Abstract][Full Text] [Related]
8. Cytoreductive surgery with selective versus complete parietal peritonectomy followed by hyperthermic intraperitoneal chemotherapy in patients with diffuse malignant peritoneal mesothelioma: a controlled study.
Baratti D; Kusamura S; Cabras AD; Deraco M
Ann Surg Oncol; 2012 May; 19(5):1416-24. PubMed ID: 22302266
[TBL] [Abstract][Full Text] [Related]
9. An Italian Multicentric Phase II study on peritonectomy and intra peritoneal hyperthermic perfusion (IPHP) to treat patients with peritoneal mesothelioma.
Deraco M; De Simone M; Rossi CR; Cavaliere F; Difilippo F; Scuderi S; Pilatti P; Kusamura S
J Exp Clin Cancer Res; 2003 Dec; 22(4 Suppl):41-5. PubMed ID: 16767905
[TBL] [Abstract][Full Text] [Related]
10. Multicystic peritoneal mesothelioma: outcomes and patho-biological features in a multi-institutional series treated by cytoreductive surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC).
Baratti D; Vaira M; Kusamura S; D'Amico S; Balestra MR; Cioppa T; Mingrone E; De Simone M; Deraco M
Eur J Surg Oncol; 2010 Nov; 36(11):1047-53. PubMed ID: 20832234
[TBL] [Abstract][Full Text] [Related]
11. The role of perioperative systemic chemotherapy in diffuse malignant peritoneal mesothelioma patients treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
Deraco M; Baratti D; Hutanu I; Bertuli R; Kusamura S
Ann Surg Oncol; 2013 Apr; 20(4):1093-100. PubMed ID: 23456386
[TBL] [Abstract][Full Text] [Related]
12. Diffuse malignant peritoneal mesothelioma: long-term survival with complete cytoreductive surgery followed by hyperthermic intraperitoneal chemotherapy (HIPEC).
Baratti D; Kusamura S; Cabras AD; Bertulli R; Hutanu I; Deraco M
Eur J Cancer; 2013 Oct; 49(15):3140-8. PubMed ID: 23831335
[TBL] [Abstract][Full Text] [Related]
13. ['Malignant peritoneal mesothelioma': a condition difficult to diagnose].
van der Valk FM; van Leeuwen J
Ned Tijdschr Geneeskd; 2012; 156(15):A4269. PubMed ID: 22495008
[TBL] [Abstract][Full Text] [Related]
14. Is Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy Justified for Biphasic Variants of Peritoneal Mesothelioma? Outcomes from the Peritoneal Surface Oncology Group International Registry.
Votanopoulos KI; Sugarbaker P; Deraco M; Morris D; Glehen O; Elias D; De Simone M; Robella M; Heyd B; Kusamura S; Baratti D; Chouliaras K; Russell G; Shen P; Levine EA;
Ann Surg Oncol; 2018 Mar; 25(3):667-673. PubMed ID: 29260418
[TBL] [Abstract][Full Text] [Related]
15. Prognostic analysis of clinicopathologic factors in 49 patients with diffuse malignant peritoneal mesothelioma treated with cytoreductive surgery and intraperitoneal hyperthermic perfusion.
Deraco M; Nonaka D; Baratti D; Casali P; Rosai J; Younan R; Salvatore A; Cabras Ad AD; Kusamura S
Ann Surg Oncol; 2006 Feb; 13(2):229-37. PubMed ID: 16444562
[TBL] [Abstract][Full Text] [Related]
16. Treatment of primary peritoneal mesothelioma by continuous hyperthermic peritoneal perfusion (CHPP).
Park BJ; Alexander HR; Libutti SK; Wu P; Royalty D; Kranda KC; Bartlett DL
Ann Surg Oncol; 1999 Sep; 6(6):582-90. PubMed ID: 10493628
[TBL] [Abstract][Full Text] [Related]
17. [Laparoscopic intraperitoneal hyperthermic perfusion in palliation of malignant ascites. Case report].
Graziosi L; Bugiantella W; Cavazzoni E; Donini A
G Chir; 2009 May; 30(5):237-9. PubMed ID: 19505418
[TBL] [Abstract][Full Text] [Related]
18. [Malignant peritoneal mesothelioma revealed by small bowel obstruction].
Béchade D; Algayres JP; Baranger B; Arborio M; Louvet C; Krulik M; Bili H; Coutant G; Daly JP
Gastroenterol Clin Biol; 2000 Dec; 24(12):1237-40. PubMed ID: 11173742
[No Abstract] [Full Text] [Related]
19. Abdominal computed tomography scans in the selection of patients with malignant peritoneal mesothelioma for comprehensive treatment with cytoreductive surgery and perioperative intraperitoneal chemotherapy.
Yan TD; Haveric N; Carmignani CP; Chang D; Sugarbaker PH
Cancer; 2005 Feb; 103(4):839-49. PubMed ID: 15637690
[TBL] [Abstract][Full Text] [Related]
20. Effectiveness of intraperitoneal hyperthermo-chemotherapy for malignant peritoneal mesothelioma and estimation of its effect by repeated FDG-PET: a case report.
Yamaguchi S; Asao T; Tsutsumi S; Fujii T; Yamauchi H; Kigure W; Morita H; Yajima R; Suto T; Kuwano H
Hepatogastroenterology; 2011; 58(107-108):861-4. PubMed ID: 21830405
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]